» Articles » PMID: 15584884

Nuclear Receptors: Overview and Classification

Overview
Date 2004 Dec 9
PMID 15584884
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

The nuclear receptor superfamily comprises a large group of transcription factors that play a key regulatory role in development and homeostasis of multicellular organisms. A special feature of nuclear receptors is their ability to bind to condensed chromatin templates, which makes them important initiators of gene transcription. Moreover, the ability of nuclear receptors to sequentially recruit a variety of transcription factors and coregulators to target promoters and to orchestrate the whole process of gene transcription confirms their biological significance and stimulates intensive research and a high level of scientific interest in this field. In this review, we summarise current knowledge regarding the structure and function of nuclear receptors as principal regulators of gene expression. Emphasis is given to the molecular mechanisms of nuclear receptor-mediated transcriptional activation and repression including recent progress made in this area.

Citing Articles

Safety Implications of Modulating Nuclear Receptors: A Comprehensive Analysis from Non-Clinical and Clinical Perspectives.

Rao M, McDuffie E, Srivastava S, Plaisted W, Sachs C Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065726 PMC: 11279859. DOI: 10.3390/ph17070875.


Concurrent Resistance and Cardiorespiratory Training in Patients with Hypertrophic Cardiomyopathy: A Pilot Study.

Bayonas-Ruiz A, Munoz-Franco F, Sabater-Molina M, Martinez-Gonzalez-Moro I, Gimeno-Blanes J, Bonacasa B J Clin Med. 2024; 13(8).

PMID: 38673596 PMC: 11050913. DOI: 10.3390/jcm13082324.


Mechanism of antagonist ligand binding to REV-ERBα.

Rahman M, Hegazy L Sci Rep. 2024; 14(1):8401.

PMID: 38600172 PMC: 11006950. DOI: 10.1038/s41598-024-58945-4.


Targeting Nuclear Receptors for T17-Mediated Inflammation: REV-ERBerations of Circadian Rhythm and Metabolism.

Mosure S, Wilson A, Solt L Immunometabolism. 2022; 4(2).

PMID: 35475255 PMC: 9038092. DOI: 10.20900/immunometab20220006.


In Silico Study Approach on a Series of 50 Polyphenolic Compounds in Plants; A Comparison on the Bioavailability and Bioactivity Data.

Stefaniu A, Pirvu L Molecules. 2022; 27(4).

PMID: 35209203 PMC: 8878759. DOI: 10.3390/molecules27041413.